Sep 2026 (Q3 FY26) — Oct 22, 2026
The Vita Coco Company Q3 FY26 — Strong Demand Continues Amidst Supply Constraints
Read the full callVita Coco Company earnings: last reported Thu, 22 Oct 2026, for the quarter ended Sep 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 244 | +33.7% YoY | Quarterly, as filed | Quarter to Sep 2026 | Revenue from operations as filed. |
| Operating margin | 18.6 | +3.3 pts YoY | Operating profit / revenue | Quarter to Sep 2026 | For the quarter; a change is in percentage points. |
| Net profit | 35.0 | +45.9% YoY | Quarterly, as filed | Quarter to Sep 2026 | Profit after tax as filed. |
Guidance
8 of 11 judged targets kept · 23 open · verdicts reflect calls analysed to Sep 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Adjusted EBITDA | $122 million to $128 million | Dec 2025 | We now expect net sales between $810 million and $820 million with expected gross margins for the full year of approximately 40%, delivering adjusted EBITDA of $170 million to $175 million. | Revised Up |
| Capacity utilization | 85% | Sep 2026 | should allow us to operate under our preferred 85% utilization model in 2028 based on our current assumptions of growth trends and capacity timing. | New |
3 of Vita Coco Company, Inc.'s 34 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 32 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $40.85 on 22 Oct 2025 → $56.53. High $84.02 (18 Jun 2026), low $39.67 (24 Oct 2025).
Overview
Guidance
8 of 11 judged targets kept · 23 open · verdicts reflect calls analysed to Sep 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Adjusted EBITDA | $122 million to $128 million | Dec 2025 | We now expect net sales between $810 million and $820 million with expected gross margins for the full year of approximately 40%, delivering adjusted EBITDA of $170 million to $175 million. | Revised Up |
| Capacity utilization | 85% | Sep 2026 | should allow us to operate under our preferred 85% utilization model in 2028 based on our current assumptions of growth trends and capacity timing. | New |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 34 tracked commitments, with each call’s wording and source.
Call summaries
The Vita Coco Company Q3 FY26 — Strong Demand Continues Amidst Supply Constraints
Read the full callThe Vita Coco Company Q2 FY26 — Strong Growth Continues, Strategic Copra Acquisition
Read the full callThe Vita Coco Company Q1 FY26 — Strong Sales Growth and Raised Full-Year Outlook
Read the full callEvery analysed call
Financials
Net profit, year on year: +46% (quarter to sep 2026 against sep 2025).
| Line item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 127 | 131 | 169 | 182 | 128 | 180 | 216 | 244 |
| Operating profit | 4 | 19 | 25 | 28 | 10 | 34 | 63 | 45 |
| Operating margin | 3.4% | 14.7% | 14.9% | 15.3% | 8.0% | 18.7% | 29.2% | 18.6% |
| Other income | -3 | 5 | 3 | 3 | -0 | 4 | 1 | -2 |
| Interest | 0 | — | — | — | — | — | — | — |
| Profit before tax | 2 | 24 | 28 | 31 | 10 | 37 | 64 | 44 |
| Tax rate | −104.1% | 22.5% | 18.7% | 21.8% | 43.4% | 18.6% | 23.2% | 19.7% |
| Net profit | 3 | 19 | 23 | 24 | 6 | 30 | 49 | 35 |
| EPS ($ per share) | — | 0.33 | 0.40 | 0.42 | — | 0.53 | 0.86 | 0.61 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | — | 28 | 47 | 55 | 101 | 157 | 228 |
| Total liabilities | — | 82 | 74 | 57 | 83 | 104 | 130 |
| Fixed assets | — | 3 | 2 | 2 | 2 | 2 | 9 |
| Total assets | — | 184 | 197 | 198 | 286 | 362 | 461 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 22 | 33 | -16 | -11 | 107 | 43 | 47 |
| Cash from investing | -1 | -0 | -1 | -1 | -1 | -1 | -8 |
| Cash from financing | -10 | 2 | -27 | 3 | 6 | -8 | -8 |
| Net cash flow | 11 | 35 | -43 | -9 | 113 | 33 | 32 |
| Capital expenditure | -1 | -0 | -1 | -1 | -1 | -1 | -8 |
| Free cash flow | 21 | 33 | -17 | -12 | 107 | 42 | 39 |
International grew from 14% to 19% of revenue over the last two years.
| Segment | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Americas | 86% | 86% | 84% | 83% | 80% | 82% | 80% | 81% | +30.9% |
| International | 14% | 14% | 16% | 17% | 20% | 18% | 20% | 19% | +48.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Q1 FY2026 · share of revenue
As COCO cuts its regions in its filings; they can nest, so they need not add to 100%.
158 filings between Oct 29, 2025 and Aug 15, 2026.
Purchases
None
No insider bought shares.
Sales
$88.92M
77 sales by 11 insiders
99% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Liran Ira | — | $38.83M | Jun 12, 2026 |
| Burth Jonathan | — | $16.36M | Jun 11, 2026 |
| Roper Martin | — | $13.72M | Apr 29, 2026 |
| Kirban Michael | — | $8.55M | Apr 30, 2026 |
| Prior Jane | — | $3.10M | Mar 5, 2026 |
| van Es Charles | — | $2.55M | Jun 1, 2026 |
| Sadowsky Kenneth | — | $2.45M | Jun 17, 2026 |
| LEAHY JOHN D | — | $1.53M | Mar 2, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 15, 2026 | Prior Jane Chief Marketing Officer | Tax withheld | 10,801 | $704.3K |
| Aug 15, 2026 | van Es Charles Chief Commercial Officer | Tax withheld | 10,801 | $704.3K |
| Aug 15, 2026 | Burth Jonathan Chief Operating Officer | Tax withheld | 10,801 | $704.3K |
| Jun 17, 2026 | Sadowsky Kenneth Director | Sale 10b5-1 plan | 3,900 | $323.4K |
| Jun 12, 2026 | Liran Ira Director | Sale 10b5-1 plan | 74,232 | $5.96M |
| Jun 12, 2026 | Liran Ira Director | Sale 10b5-1 plan | 73,842 | $5.93M |
| Jun 11, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 23,575 | $239.9K |
| Jun 11, 2026 | Liran Ira Director | Sale 10b5-1 plan | 95,768 | $7.58M |
| Jun 11, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 30,000 | $2.40M |
| Jun 11, 2026 | Liran Ira Director | Sale 10b5-1 plan | 96,158 | $7.61M |
| Jun 11, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 6,425 | $65.4K |
| Jun 3, 2026 | Zupo John Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | Broader Shelley G Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | Dozie Aishetu Fatima Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | Melloul Eric Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | Liran Ira Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | MORREAU JANE C Director | Award | 1,530 | $115.0K |
| Jun 3, 2026 | Sadowsky Kenneth Director | Award | 1,530 | $115.0K |
| Jun 1, 2026 | van Es Charles Chief Commercial Officer | Sale 10b5-1 plan | 8,045 | $603.8K |
| May 20, 2026 | Sadowsky Kenneth Director | Sale 10b5-1 plan | 3,900 | $302.2K |
| May 12, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 30,000 | $2.25M |
| May 12, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 30,000 | $305.3K |
| May 8, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 20,000 | $203.6K |
| May 8, 2026 | van Es Charles Chief Commercial Officer | Sale 10b5-1 plan | 8,561 | $599.3K |
| May 8, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 20,000 | $1.40M |
| May 1, 2026 | van Es Charles Chief Commercial Officer | Sale 10b5-1 plan | 2,000 | $133.7K |
| Apr 30, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 20,000 | $203.6K |
| Apr 30, 2026 | Kirban Michael Executive Chairman | Sale 10b5-1 plan | 50,000 | $3.40M |
| Apr 30, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 20,000 | $1.35M |
| Apr 29, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 20,000 | $1.25M |
| Apr 29, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 20,000 | $203.6K |
| Apr 29, 2026 | Burth Jonathan Chief Operating Officer | Sale 10b5-1 plan | 20,000 | $1.30M |
| Apr 29, 2026 | Burth Jonathan Chief Operating Officer | Option exercise 10b5-1 plan | 20,000 | $203.6K |
| Apr 29, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 20,544 | $209.1K |
| Apr 29, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 20,544 | $1.22M |
| Apr 28, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.28M |
| Apr 28, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 27, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.25M |
| Apr 27, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 24, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 24, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.25M |
| Apr 16, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.25M |
| Apr 16, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 15, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.25M |
| Apr 15, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 15, 2026 | Sadowsky Kenneth Director | Sale 10b5-1 plan | 3,900 | $190.8K |
| Apr 14, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 25,000 | $254.5K |
| Apr 14, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 25,000 | $1.25M |
| Apr 13, 2026 | Roper Martin Chief Executive Officer | Option exercise 10b5-1 plan | 4,456 | $45.4K |
| Apr 13, 2026 | Roper Martin Chief Executive Officer | Sale 10b5-1 plan | 4,456 | $225.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Vita Coco Company, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading